Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

27.68 -1.99 (-6.71%)

Official Closing Price Updated: 4:10 PM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

64 65 Next >

Is Hims & Hers Stock an Undervalued Stock to Buy? ↗

June 01, 2026

The healthcare industry is ripe for disruption.

Via The Motley Fool

Hims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners

May 28, 2026

From Hims & Hers

Via Business Wire

Hims & Hers Eyes Global Growth: Will $1.15B Eucalyptus Deal Fuel Its Recovery or Dilute Shareholders? ↗

May 28, 2026

Hims & Hers is acquiring Australian telehealth platform Eucalyptus as part of its international expansion plan while using $350 million in convertible senior notes.

Via MarketBeat

Topics Earnings

Hims & Hers Shares Rally On Million-Dollar Insider Purchase ↗

May 27, 2026

Shares of Hims & Hers Health Inc (NYSE: HIMS) are trading higher Wednesday morning after insider stock purchase boosts investor confidence.

Via Benzinga

Hims & Hers Health (NYSE:HIMS) Misses Q1 2026 Estimates, Shares Drop on GLP-1 Pivot Costs ↗

May 11, 2026

Via Chartmill

The Silver Lining of Last Week's Hims & Hers Earnings Miss ↗

May 21, 2026

Hims & Hers plunged 23% after a major Q1 earnings miss, but long-term growth stays intact via its Novo Nordisk GLP-1 partnership and a late 2026 expansion.

Via MarketBeat

Topics Earnings

Peptide-Based Health Industry Positioned for Explosive Long-Term Growth Across Global Wellness Markets

May 21, 2026

EQNX::TICKER_START (OTCQB:PNGAF),(CSE:BPC),(NYSE:MMA),(NYSE:NVO),(NYSE:HIMS),(NYSE:LLY) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Government

Hims & Hers Expands GLP-1 Offering in Canada with Generic Semaglutide

May 21, 2026

From Hims & Hers

Via Business Wire

Peptide-Based Health Industry Positioned for Explosive Long-Term Growth Across Global Wellness Markets

May 21, 2026

Analysts project billions in future market value as biotech innovation and consumer demand continue driving the next wave of health performance products

From MarketNewsUpdates.com

Via GlobeNewswire

Hims & Hers Massive Stock Drop Explained ↗

May 19, 2026

Raising debt increases the risk in Hims & Hers' stock.

Via The Motley Fool

Hims & Hers Stock Stabilizes After Upsized $350 Million Convertible Note Offering ↗

May 19, 2026

Hims & Hers Health (NYSE: HIMS) shares are trading flat in Tuesday's pre-market as traders continue to digest its convertible notes offering.

Via Benzinga

Hims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment

May 18, 2026

From Hims & Hers

Via Business Wire

Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment

May 18, 2026

From Hims & Hers

Via Business Wire

5 Revealing Analyst Questions From Hims & Hers Health’s Q1 Earnings Call

May 18, 2026

Hims & Hers Health’s first quarter was marked by a significant strategic pivot in its weight loss business, which management described as a move to prioritiz...

Via StockStory

Topics Earnings Economy

Spotting Winners: Hims & Hers Health (NYSE:HIMS) And Healthcare Technology Stocks In Q1

May 17, 2026

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the healthcare technology stocks, including Hims & Hers Health (NYSE:HIMS) and its peer...

Via StockStory

Hims & Hers Stock Drops After Earnings: Buying Opportunity or Warning Sign? ↗

May 15, 2026

Hims & Hers continues growing rapidly, but shrinking margins and rising costs are beginning to test the company's long-term profitability story.

Via The Motley Fool

Topics Artificial Intelligence

Is Hims and Hers Health Stock a Buy After Its Latest Dip? ↗

May 14, 2026

The stock continues to be very volatile.

Via The Motley Fool

1 Small-Cap Stock to Target This Week and 2 We Turn Down

May 14, 2026

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th...

Via StockStory

A Hot CPI, Chips in Retreat, and $100 Oil: Tuesday's Market in Four Acts ↗

May 13, 2026

Via Chartmill

Hims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery? ↗

May 12, 2026

Hims & Hers Health posted a Q1 FY2026 double miss, with an EPS loss of $0.40 and revenue of $608.1 million, sending shares down more than 12% after hours.

Via MarketBeat

Topics Intellectual Property Lawsuit

Why Hims & Hers Health Stock Just Crashed ↗

May 12, 2026

Hims & Hers is unshaken by its earnings miss, with management promising even faster sales growth this year.

Via The Motley Fool

Topics Earnings Lawsuit

Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates

May 12, 2026

EQNX::TICKER_START (OTCQB:PNGAF),(CSE:BPC),(NYSE:PFE),(NYSE:NVO),(NYSE:HIMS),(NYSE:LLY) EQNX::TICKER_END

Via FinancialNewsMedia

Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates

May 12, 2026

Next-generation wellness platforms targeting longevity, metabolism, and performance continue gaining momentum in one of healthcare’s fastest-growing sectors

From MarketNewsUpdates.com

Via GlobeNewswire

Chips Push the S&P 500 to 7,400, Supercycle or the Last Act of a Bubble? ↗

May 12, 2026

Via Chartmill

Topics Stocks

HIMS Q1 Deep Dive: Strategic Pivot in Weight Loss and Margin Pressures Shape Outlook

May 12, 2026

Telehealth company Hims & Hers Health (NYSE:HIMS) fell short of the market’s revenue expectations in Q1 CY2026 as sales rose 3.8% year on year to $608.1 mill...

Via StockStory

Topics Artificial Intelligence

Hims & Hers Health Q1 Earnings Call Highlights ↗

May 12, 2026

Hims & Hers Health (NYSE:HIMS) reported first-quarter 2026 revenue growth and raised its full-year revenue outlook, while executives said a strategic shift in the company’s weight-loss business is...

Via MarketBeat

Topics Artificial Intelligence Earnings

Hims HIMS Q1 2026 Earnings Call Transcript ↗

May 11, 2026

Hims HIMS Q1 2026 Earnings Call Transcript

Via The Motley Fool

Topics Earnings Economy

Hims & Hers Health (NYSE:HIMS) Misses Q1 CY2026 Sales Expectations, Stock Drops 11.5%

May 11, 2026

Telehealth company Hims & Hers Health (NYSE:HIMS) missed Wall Street’s revenue expectations in Q1 CY2026 as sales rose 3.8% year on year to $608.1 million. O...

Via StockStory

Hims & Hers Health, Inc. Reports First Quarter 2026 Financial Results

May 11, 2026

From Hims & Hers

Via Business Wire

Hims & Hers Health (HIMS) Reports Q1: Everything You Need To Know Ahead Of Earnings

May 09, 2026

Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting results this Monday after the bell. Here’s what to expect. Hims & Hers Health met analyst...

Via StockStory

Topics Artificial Intelligence

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

64 65 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.